Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
374M
-
Number of holders
-
75
-
Total 13F shares, excl. options
-
43.7M
-
Shares change
-
-5.49M
-
Total reported value, excl. options
-
$69.9M
-
Value change
-
-$16.2M
-
Put/Call ratio
-
1.31
-
Number of buys
-
39
-
Number of sells
-
-57
-
Price
-
$1.60
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) as of Q2 2022
121 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share as of Q2 2022.
STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) has 75 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.7M shares
of 374M outstanding shares and own 11.67% of the company stock.
Largest 10 shareholders include Indaba Capital Management, L.P. (7.45M shares), PRIMECAP MANAGEMENT CO/CA/ (4.96M shares), Neuberger Berman Group LLC (3.97M shares), NEEDHAM INVESTMENT MANAGEMENT LLC (3.87M shares), VANGUARD GROUP INC (3.56M shares), MORGAN STANLEY (3.1M shares), BOOTHBAY FUND MANAGEMENT, LLC (2.32M shares), BlackRock Inc. (2.02M shares), RA CAPITAL MANAGEMENT, L.P. (1.99M shares), and MILLENNIUM MANAGEMENT LLC (1.35M shares).
This table shows the top 75 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.